The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy

European Journal of Neurology

Volumn 18, Issue 6, 2011, Pages 919-924

  Bohn, A B ^a,b   Nederby, L ^a   Harbo, T ^b   Skovbo, A ^a   Vorup Jensen, T ^a   Krog, J ^b   Jakobsen, J ^b   Hokland, M E ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CD16 (Fc RIIIa); Chronic inflammatory demyelinating polyradiculoneuropathy; Intravenous immunoglobulin; Natural killer cells

Indexed keywords

CD16 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY TEST; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYRADICULONEUROPATHY; PRIORITY JOURNAL;

ADULT; AGED; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RECEPTORS, FC; RECEPTORS, IGG; YOUNG ADULT;

EID: 79955711573     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03333.x     Document Type: Article

References (27)

1. Gold R, Stangel M, Dalakas MC. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Nat Clin Pract Neurol, 2007; 3: 36-44.
2. Hughes RA, Donfrio P, Bril V, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol, 2008; 7: 136-144.
3. Hughes RA. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Expert Rev Neurother, 2009; 9: 789-795.
4. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 2001; 291: 484-486.
5. Jarius S, Eichhorn P, Albert MH, et al. Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent way. Blood, 2007; 109: 4376-4382.
6. Tackenberg B, Jelcic I, Baerenwaldt A, et al. Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci U S A, 2009; 106: 4788-4792.
7. Créange A, Gregson NA, Hughes RAC. Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies. J Neuroimmunol, 2003; 135: 91-95.
8. Dalakas MC. Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases. JAMA, 2004; 291: 2367.
9. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol, 2005; 5: 112-124.
10. Perricone R, Perricone C, De Carolis C, Schoenfeld Y. NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev, 2008; 7: 384-390.
11. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer?. Nat Rev Immunol, 2003; 3: 413-425.
12. Iannello A, Ahmad A. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Cancer Metastasis Rev, 2005; 24: 487-499.
13. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol, 2006; 118: 1-10.
14. Kuitwaard K, de Gelder J, Tio Gillen AP, et al. Phamacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol, 2009; 66: 597-603.
15. Hughes RA, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol, 2006; 13: 326.
16. Sinnreich M, Klein CJ, Daube JR, Engelstad J, Spinner RJ, Dyck PJ. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology, 2004; 63: 1662-1669.
17. Merkies IS, Schmitz PI, van der Merché FG, Samijn JP, van Doorn PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry, 2002; 72: 596-601.
18. Bleeker WK, Lammerts van Bueren JJ, van Ojik HH, et al. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy. J Immunol, 2004; 173: 4699-4707.
19. Perricone R, Di Muzio G, Perricone C, et al. High Levels of Peripheral Blood NK Cells in Woman Suffering from Recurrent Spontaneus Abortion are Reverted from High-Dose Intravenous Immunoglobulins. Am J Reprod Immunol, 2006; 55: 232-239.
20. Engelhard D, Waner JL, Kapoor N, Good RA. Effect of intravenous immune globulin on natural killer cell. J Pediatr, 1986; 108: 77-81.
21. Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemestry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve, 1997; 20: 1102-1107.
22. Zhang QY, Huang JH, Li HZ, et al. Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis. Arch Med Res 2008; 39: 45-51.
23. Vanguri P, Lee E, Henkart P, Shin ML. Hydrolysis of Myelin Basic protein in Myelin Membranes by Granzymes of Large Granular Lymphocytes. J Immunol, 1993; 150: 2431-2439.
24. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science, 2004; 306: 1517-1519.
25. Penack O, Gentilini C, Fischer L, et al. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia, 2005; 19: 835-840.
26. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev, 2006; 20: 123-137.
27. Fleit HB, Wright SD, Unkeless JC. Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci U S A, 1982; 79: 3275-3279.